Health professionals' views of current treatment pathways for cancer patients with comorbid diabetes

      Background: Cancer and diabetes mellitus (DM) are leading causes of death worldwide and the incidence of both is ever-increasing. People with both diseases are at increased risk of poorer health outcomes (1). Reasons for this are unclear but may include poorer DM monitoring and self-management, and suboptimal treatment of DM and/or cancer, leading to worsened glycaemic control.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect